VeraMorph
Mansfield, US · Founded 2022 · Delaware corporation · 1 known investors
Find your way into VeraMorph
707 people in our graph share verified history with the VeraMorph team — schools, employers, funds. One of them is your warm intro.
Lauren von Reynunlockedknows Doug Godfrin · together at University of Virginia (overlapped)
×6knows the team · via Department of Chemical Engineering, MIT
×5knows the team · via University of Virginia
VeraMorph is a drug delivery company that has developed a proprietary oral drug delivery platform used to improve solubility and clinical translation of poorly soluble compounds. It works with pharmaceutical companies and is building a portfolio of clinically differentiated oral versions of approved drugs.
Founders & leadership
VeraMorph was founded in 2022 by Paul D. Godfrin and Doug Godfrin.
PD
Paul D. GodfrinCo-founder
DG
Doug GodfrininFounder, CEO & PresidentHe has expertise in colloidal science, pharmaceutical formulations, and functional materials.
Investors · 1
Reported raises · per SEC filings
Form D private placements$262.3K disclosed across 2 rounds · 2022–2023
▶$40KraisedApr 2023 · 1 investors · BiotechnologyRule 506(b)
▶$40KraisedApr 2023 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Paul D. GodfrinExecutive Officer, Director
- Offering amount
- $500K
- Amount sold
- $40K
- First sale
- Mar 2023
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
▶$222.3KraisedAug 2022 · 2 investors · BiotechnologyRule 506(b)
▶$222.3KraisedAug 2022 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Paul D. GodfrinExecutive Officer, Director
- Offering amount
- $1M
- Amount sold
- $222.3K
- First sale
- Aug 2022
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- What does VeraMorph do?
- VeraMorph is a drug delivery company that has developed a proprietary oral drug delivery platform used to improve solubility and clinical translation of poorly soluble compounds. It works with pharmaceutical companies and is building a portfolio of clinically differentiated oral versions of approved drugs.
- Who founded VeraMorph?
- VeraMorph was founded by Paul D. Godfrin, Doug Godfrin in 2022.
- Who are VeraMorph's investors?
- VeraMorph's investors include The Innovation Space.
- How much funding has VeraMorph raised?
- VeraMorph has disclosed $262.3K raised across 2 rounds.
- Where is VeraMorph headquartered?
- VeraMorph is headquartered in Mansfield, US.